Late adverse effects of childhood acute lymphoblastic leukemia treatment on developing dentition

被引:8
|
作者
Immonen, Egle [1 ,2 ]
Nikkila, Atte [1 ,3 ,4 ]
Peltomaki, Timo [2 ,5 ,6 ]
Aine, Liisa [2 ,5 ]
Lohi, Olli [1 ,3 ,4 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere, Finland
[2] Tampere Univ Hosp, Dept Ear & Oral Dis, Tampere, Finland
[3] Tampere Univ, Tays Canc Ctr, Tampere, Finland
[4] Tampere Univ Hosp, Tampere, Finland
[5] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[6] Univ Eastern Finland, Inst Dent, Kuopio, Finland
关键词
defect; dentition; development; leukemia; survivor; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; DENTAL ANOMALIES; RISK-FACTORS; ORAL-HEALTH; CHILDREN; CANCER; CHEMOTHERAPY; SURVIVORS; ABNORMALITIES;
D O I
10.1002/pbc.29200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Childhood cancer survivors show a variety of late adverse effects on dental health. The purpose of this study was to examine the prevalence and severity of dental abnormalities in permanent dentition in childhood leukemia survivors. Materials and methods Retrospective analysis of panoramic radiographs was performed for 178 childhood leukemia survivors aged below 17 years at the time of diagnosis. Sex, age at diagnosis, interval between ALL diagnosis and the follow-up radiograph, treatment protocol, and risk grouping were recorded. Abnormalities of tooth development and defect index were used to assess the frequency and severity of dental abnormalities. Results One hundred eight (61%) patients had no dental abnormalities at follow-up examination at a median of 6.1 years after diagnosis. Microdontia was more frequent in children under 6 years of age at the time of diagnosis (5.7% vs. 0.6%, p < .001). Significant differences were noted between distinct ALL treatment protocols with more common microdontia in patients treated according to the NOPHO ALL2008 protocol. Tooth agenesis was more frequent in patients that underwent therapy according to high-risk arms compared to intermediate- or standard-risk arms (3.8% vs. 1.4%, p = .01). Patients under 6 years of age at diagnosis had a significantly higher average defect index score than older patients (7.0 vs. 2.8, p = .01). Conclusions Children and adolescents who received ALL treatment were at risk for dental damage. Young age and high-intensity therapy were associated with the severity of dental abnormalities.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - THE LATE EFFECTS OF TREATMENT
    CHESSELLS, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1983, 53 (03) : 369 - 378
  • [2] The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors
    Marcoux, Sophie
    Drouin, Simon
    Laverdiere, Caroline
    Alos, Nathalie
    Andelfinger, Gregor U.
    Bertout, Laurence
    Curnier, Daniel
    Friedrich, Matthias G.
    Kritikou, Ekaterini A.
    Lefebvre, Genevieve
    Levy, Emile
    Lippe, Sarah
    Marcil, Valerie
    Raboisson, Marie-Josee
    Rauch, Frank
    Robaey, Philippe
    Samoilenko, Mariia
    Seguin, Chantal
    Sultan, Serge
    Krajinovic, Maja
    Sinnett, Daniel
    PEDIATRIC BLOOD & CANCER, 2017, 64 (06)
  • [3] Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors
    A. Shalmiev
    G. Nadeau
    M. Aaron
    E. Ouimet-Grennan
    S. Drouin
    L. Bertout
    P. Beaulieu
    P. St-Onge
    L.-N. Veilleux
    F. Rauch
    A. Rezgui
    K. Petrykey
    C. Laverdière
    D. Sinnett
    N. Alos
    M. Krajinovic
    The Pharmacogenomics Journal, 2022, 22 : 19 - 24
  • [4] Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors
    Shalmiev, A.
    Nadeau, G.
    Aaron, M.
    Ouimet-Grennan, E.
    Drouin, S.
    Bertout, L.
    Beaulieu, P.
    St-Onge, P.
    Veilleux, L. -N.
    Rauch, F.
    Rezgui, A.
    Petrykey, K.
    Laverdiere, C.
    Sinnett, D.
    Alos, N.
    Krajinovic, M.
    PHARMACOGENOMICS JOURNAL, 2022, 22 (01): : 19 - 24
  • [5] Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors
    Kizilocak, Hande
    Okcu, Fatih
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (01) : 1 - 11
  • [6] Late recurrence of childhood acute lymphoblastic leukemia
    Geetha, N
    Lali, VS
    Nileena, N
    Nair, MK
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02): : 191 - 192
  • [7] Neurocognitive late effects in adult survivors of childhood acute lymphoblastic leukemia
    Edelstein, K.
    D'Agostino, N.
    Hodgson, D.
    Nathan, P.
    Greenberg, M.
    Millar, B.
    Laperriere, N.
    Spiegler, B. J.
    CLINICAL NEUROPSYCHOLOGIST, 2008, 22 (03) : 442 - 443
  • [8] Treatment of Childhood Acute Lymphoblastic Leukemia
    Stanulla, Martin
    Schrappe, Martin
    SEMINARS IN HEMATOLOGY, 2009, 46 (01) : 52 - 63
  • [9] Treatment of Acute Lymphoblastic Leukemia in Childhood
    Schrappe, Martin
    ANNALS OF HEMATOLOGY, 2017, 96 : S35 - S36
  • [10] Late pulmonary adverse effects in childhood survivors of acute lymphoblastic leukemia; A national cross-sectional study
    Meyer, Sonja Izquierdo
    Nielsen, Kim Gjerum
    Rubak, Sune
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64